J Acquir Immune Defic Syndr
-
Publication Venue For
-
Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV..
90:377-381.
2022
-
Identification of Determinants and Implementation Strategies to Increase PrEP Uptake Among Black Same Gender-Loving Men in Mecklenburg County, North Carolina: The PrEP-MECK Study..
90:S149-S160.
2022
-
Brief Report: Blood and Genital Fluid Viral Load Trajectories Among Treated and Untreated Persons With Acute HIV Infection in Malawi..
90:56-61.
2022
-
Cardiorespiratory Fitness Is Associated With Better White Matter Integrity in Persons Living With HIV..
89:558-565.
2022
-
Prevalence and Correlates of Electrocardiographic Abnormalities in Adults With HIV: Insights From the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)..
89:349-359.
2022
-
Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States..
88:10-18.
2021
-
Trajectories of Depressive Symptoms, Neurocognitive Function, and Viral Suppression With Antiretroviral Therapy Among Youth With HIV Over 36 months..
87:851-859.
2021
-
Perceived Interruptions to HIV Prevention and Treatment Services Associated With COVID-19 for Gay, Bisexual, and Other Men Who Have Sex With Men in 20 Countries..
87:644-651.
2021
-
Understanding the HIV Epidemic Among MSM in Baltimore: A Modeling Study Estimating the Impact of Past HIV Interventions and Who Acquired and Contributed to Infections..
84:253-262.
2020
-
Brief Report: Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01..
83:434-439.
2020
-
Crowdsourcing Methods to Enhance HIV and Sexual Health Services: A Scoping Review and Qualitative Synthesis..
82 Suppl 3:S271-S278.
2019
-
Hypertension Control and Retention in Care Among HIV-Infected Patients: The Effects of Co-located HIV and Chronic Noncommunicable Disease Care..
82:399-406.
2019
-
Brief Report: Kidney Dysfunction Does Not Contribute Significantly to Antiretroviral Therapy Modification in Treatment-Naive PLWH Receiving Initial ART..
81:e6-e9.
2019
-
Prediction of HIV Transmission Cluster Growth With Statewide Surveillance Data..
80:152-159.
2019
-
Leveraging Phylogenetics to Understand HIV Transmission and Partner Notification Networks..
78:367-375.
2018
-
Brief Report: Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis..
77:206-211.
2018
-
Partnerships Between a University-Affiliated Clinic and Community-Based Organizations to Reach Black Men Who Have Sex With Men for PrEP Care..
77:e25-e27.
2018
-
HIV Preexposure Prophylaxis Implementation at Local Health Departments: A Statewide Assessment of Activities and Barriers..
77:72-77.
2018
-
The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care..
76:402-408.
2017
-
Social Network Clustering and the Spread of HIV/AIDS Among Persons Who Inject Drugs in 2 Cities in the Philippines..
76:26-32.
2017
-
Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay..
75:241-245.
2017
-
The Impact of Preexposure Prophylaxis Among Men Who Have Sex With Men: An Individual-Based Model..
75:175-183.
2017
-
PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi..
74:367-374.
2017
-
Complications and Route of Delivery in a Large Cohort Study of HIV-1-Infected Women-IMPAACT P1025..
73:74-82.
2016
-
Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021..
72:372-375.
2016
-
Characteristics of Age-Discordant Partnerships Associated With HIV Risk Among Young South African Women (HPTN 068)..
72:423-429.
2016
-
High-Frequency Illegitimate Strand Transfers of Nascent DNA Fragments During Reverse Transcription Result in Defective Retrovirus Genomes..
72:353-362.
2016
-
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial..
72:31-38.
2016
-
Participants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial..
71:452-461.
2016
-
Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis..
71:374-380.
2016
-
Incorporating Acute HIV Screening into Routine HIV Testing at Sexually Transmitted Infection Clinics, and HIV Testing and Counseling Centers in Lilongwe, Malawi..
71:272-280.
2016
-
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women..
71:137-145.
2016
-
Feasibility of a Combination HIV Prevention Program for Men Who Have Sex With Men in Blantyre, Malawi..
70:155-162.
2015
-
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds..
70:42-53.
2015
-
Comprehensive Characterization of the Transmitted/Founder env Genes From a Single MSM Cohort in China..
69:403-412.
2015
-
Outcomes Up to 12 Months After Treatment With Loop Electrosurgical Excision Procedure for Cervical Intraepithelial Neoplasia Among HIV-Infected Women..
69:200-205.
2015
-
Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061..
69:52-60.
2015
-
The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills..
68:578-584.
2015
-
Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP..
67:555-563.
2014
-
Effects of a couple-based intervention to reduce risks for HIV, HCV, and STIs among drug-involved heterosexual couples in Kazakhstan: a randomized controlled trial..
67:196-203.
2014
-
HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research..
67 Suppl 1:S40-S53.
2014
-
Enhancing benefits or increasing harms: community responses for HIV among men who have sex with men, transgender women, female sex workers, and people who inject drugs..
66 Suppl 3:S319-S328.
2014
-
FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis..
66:324-331.
2014
-
Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya..
66:188-192.
2014
-
World Health Organization's stage 4 conditions among adults accessing outpatient HIV care: a retrospective cohort study in Kisumu, Kenya..
65:e152-e155.
2014
-
Postpartum depression and HIV infection among women in Malawi..
65:359-365.
2014
-
Reduced adherence to antiretroviral therapy among HIV-infected Tanzanians seeking cure from the Loliondo healer..
65:e104-e109.
2014
-
Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV disease..
64:382-391.
2013
-
Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy..
64:374-381.
2013
-
Overcoming biological, behavioral, and structural vulnerabilities: new directions in research to decrease HIV transmission in men who have sex with men..
63 Suppl 2:S161-S167.
2013
-
Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation..
62:505-508.
2013
-
Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa..
62:e55-e57.
2013
-
PEPFAR's evolving HIV prevention approaches for key populations--people who inject drugs, men who have sex with men, and sex workers: progress, challenges, and opportunities..
60 Suppl 3:S145-S151.
2012
-
Childhood trauma and health outcomes in HIV-infected patients: an exploration of causal pathways..
59:409-416.
2012
-
HIV/HCV-coinfected natural viral suppressors have better virologic responses to PEG-IFN and ribavirin than ARV-treated HIV/HCV patients..
58:e38-e40.
2011
-
Expanding the space: inclusion of most-at-risk populations in HIV prevention, treatment, and care services..
57 Suppl 2:S96-S99.
2011
-
Mental health and HIV sexual risk behavior among patrons of alcohol serving venues in Cape Town, South Africa..
57:230-237.
2011
-
A cost-effectiveness analysis of alternative HIV retesting strategies in sub-saharan Africa..
56:443-452.
2011
-
Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire..
56:356-364.
2011
-
Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy..
56:83-90.
2011
-
Acute Dengue fever causes false-positive reactivity in OraQuick rapid HIV-1/2 antibody test..
55:641.
2010
-
Epidemiologic links between drug use and HIV epidemics: an international perspective..
55 Suppl 1:S10-S16.
2010
-
HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study..
55:65-72.
2010
-
Predicting virologic failure among HIV-1-infected children receiving antiretroviral therapy in Tanzania: a cross-sectional study..
54:368-375.
2010
-
Results of the NIMH collaborative HIV/sexually transmitted disease prevention trial of a community popular opinion leader intervention..
54:204-214.
2010
-
Characteristics of HIV voluntary counseling and testing clients before and during care and treatment scale-up in Moshi, Tanzania..
52:648-654.
2009
-
Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia After Prison Release: The imPACT Trial.
2017
-
Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care.
2016